当前位置: X-MOL 学术Lancet Psychiatry › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Research round-up
The Lancet Psychiatry ( IF 64.3 ) Pub Date : 2017-11-01 , DOI: 10.1016/s2215-0366(17)30403-0
Seema Kang

Batelaan and colleagues examine risk of relapse in people with remitted anxiety disorders after tapering of antidepressant medication. In their meta-analysis of 28 studies, comprising 5233 participants followed for up to 12 months, a higher risk of relapse was found after antidepressant medication cessation than with continuation (summary odds ratio [OR] 3·11, 95% CI 2·48–3·89; I2=8·07%). Additionally, analysis of 11 studies (n=3002) suggested that discontinuation of antidepressant medication led to relapse occurring sooner than in people who continued medication (summary hazard ratio [HR] 3·63, 95% CI 2·58–5·10; I2=0%).

中文翻译:

研究综述

Batelaan和他的同事研究了逐渐减少的抗抑郁药物治疗后,缓解的焦虑症患者复发的风险。在他们对28项研究的荟萃分析中,包括5233名参与者,随访时间长达12个月,发现抗抑郁药停药后复发的风险高于继续治疗(总比值比[OR] 3·11,95%CI 2·48 –3·89;I 2 = 8·07%)。此外,对11项研究(n = 3002)的分析表明,停止服用抗抑郁药比复发的人更快地复发(总危险比[HR] 3·63,95%CI 2·58-5·10;2 = 0%)。
更新日期:2017-10-28
down
wechat
bug